Wuxi Biologics files IPO prospectus aiming to be gateway to China

The initial public offering (IPO) prospectus does not set an expected value or date … It also revealed that is works with Taiwan-based TaiMed Biologics, Israel’s OPKO Biologics, Hong Kong’s CStone Pharmaceutical. Wuxi Biologics manufacturing and …
( read original story …)